FOLLICULAR LYMPHOMAS:-Reference-Cited by-同舟云学术

FOLLICULAR LYMPHOMAS:

Published:1997-10 Issue:5 Volume:11 Page:893-900
ISSN:0889-8588
Container-title:Hematology/Oncology Clinics of North America
language:en
Short-container-title:Hematology/Oncology Clinics of North America

Author:

Miller Thomas P.,LeBlanc Michael,Grogan Thomas M.,Fisher Richard I.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference29 articles.

1. Nodular mixed cell lymphoma: Is there a potential for prolonged disease free survival and cure?;Anderson;Controversies in the Management of Lymphomas,1983

2. Follicular large-cell lymphoma: Intermediate or low grade?;Bartlett;J Clin Oncol,1994

3. A revised European-American classification of lymphoid neoplasms proposed by the International Lymphoma Study Group;Chan;Am J Clin Pathol,1995

4. Long-term follow-up of patients with low grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy;Dana;J Clin Oncol,1993

5. Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy;Dana;Classic Papers and Current Comments,1996

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1–2 follicular lymphoma: a real-world multicenter study;Biomarker Research;2023-02-06

2. Long‐term outcome comparing histological grades of follicular lymphoma patients treated with immunochemotherapy as first‐line therapy: A retrospective analysis from two institutions;European Journal of Haematology;2019-12-22

3. Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study;The Oncologist;2018-01-09

4. Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline-Based Therapy;Clinical Lymphoma Myeloma and Leukemia;2017-08

5. SYSTEMIC FRONT LINE THERAPY OF FOLLICULAR LYMPHOMA: WHEN, TO WHOM AND HOW;Mediterranean Journal of Hematology and Infectious Diseases;2016-11-06